Coronavirus

#Antivirals #Coronavirus

Open science collaboration reveals promising new coronavirus antiviral

A promising broad-spectrum coronavirus antiviral pre-clinical candidate, ASAP-0017445, has been discovered.  ASAP-0017445 is designed to be a direct-to-generic, globally accessible treatment ready for future coronavirus pandemics. The pre-clinical drug candidate, which exhibited encouraging preliminary safety and efficacy results, was recently nominated by Drugs for Neglected Diseases initiative… Read More

#News

#Coronavirus #Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #Pandemic prevention #University of Cambridge

‘Proactive’ vaccine protects against unknown future coronaviruses

Researchers have developed a new vaccine technology that can provide protection against a broad range of coronaviruses with potential for future disease outbreaks – including ones we don’t know about yet. This approach to vaccine development is called ‘proactive vaccinology’, where scientists build a vaccine before… Read More

#Editor's Choice #News

#Coronavirus #Covid-19 #Long Covid #Omicron

Top stories: Covid-19

An update on the latest Covid-19 news by DDW Digital Content Editor Diana Spencer  With winter around the corner and cases once again on the rise, the last few weeks have seen some interesting developments related to Covid-19. We found out that Omicron infection protects against flu,… Read More

#Covid-19 #News

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#Biotherapeutics #Coronavirus #Covid-19 #Drug development

Infex filed for UK patent for coronavirus novel therapy design

Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains. The COV-X program targets a protein which is essential for viral replication across a broad spectrum of related coronaviruses, including SARS-CoV-1, MERS-CoV and SARS-CoV-2. If successfully developed, the treatment aims to form… Read More

#Covid-19 #News

#Coronavirus #Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines #Pandemic #Sitting Down With #Therapeutics

How critical is the part therapeutics have to play in the pandemic?

This DDW Sponsored Sitting Down With episode features Guy Goldberg, Chief Business Officer of RedHill Biopharma. In this episode  – Guy Goldberg discusses COVID-19 therapeutics and their role in the pandemic. Goldberg shares his market insight, the benefits of an orally-administered small molecule tablet for COVID treatment and how the… Read More

#Podcasts

#Biotechnology #Coronavirus #Covid-19 #Drug development #Drug discovery #Metabolomics #Metabolon #Narrated podcasts #Pharmaceutical

The potential of metabolomics & COVID-19 Vaccine Development

Today’s episode is titled The potential of metabolomics & COVID-19 Vaccine Development, and covers 2 articles taken from the most recent Fall issue of DDW. These articles are titled: Why metabolomics has the potential to transform diagnosis and treatment. & COVID-19 Vaccine Development: dethroning evil King Coronavirus These articles were firstly… Read More

#Podcasts